CD8A and glioblastoma: As mentioned above, in the GL261 syngeneic orthotopic GBM model, the combination of irradiated tumor cells, α-GalCer, and doxicyclin was shown to effectively induce CD8+ T cell mediated anti-tumor immune responses [100], and this efficacy was further enhanced by Treg depletion through anti-CD25 treatment.